MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Prevalence and severity of non-motor symptoms in hispanic at-risk population with REM-sleep behavior disorder.

    E. Argüelles-González, A. Jorge-de Sarachaga, R. Solís-Vivanco, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To detect non-motor symptoms in individuals at-risk for Parkinson's disease (PD) due to idiopathic REM sleep behavior disorder (RBD) and determine the rate of…
  • 2023 International Congress

    Quantitative Evaluation of Seborrheic Dermatitis in Patients with Autonomic Dysfunction.

    R. Sengoku, A. Nakahara, T. Kitagawa, M. Ikeda, H. Matsuno (Tokyo, Japan)

    Objective: We quantitatively evaluated skin condition of patients with autonomic dysfunction. Background: Dyshidrosis are known to be one of autonomic symptom in Lewy body disease…
  • 2023 International Congress

    Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?

    R. Cerroni, M. Conti, M. Pierantozzi, V. D'Angelo, N. Mercuri, A. Teofani, D. Pietrucci, G. Chillemi, V. Unida, A. Stefani (Rome, Italy)

    Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…
  • 2023 International Congress

    Underutilization of Neurology and Rehabilitation Services among People with Parkinson’s Disease

    M. Kafri, B. Naamneh Abuelhija, M. Kestenbaum, SM. Giveon, G. Yogev Seligmann (Haifa, Israel)

    Objective: to map utilization of neurology and rehabilitation services by people with Parkinson’s disease (PD), and to identify associations between utilization and demographics. Background: People…
  • 2023 International Congress

    Safety and efficacy of P2B001 (low dose combination of extended-release pramipexole and rasagiline) in patients with early Parkinson’s disease: Subgroup analyses from a randomized, controlled trial

    D. Falconer, P. Litman, H. Friedman, S. Oren, C. Fitter-Attas (Alexandria, USA)

    Objective: Evaluate the efficacy and safety of P2B001 for different subgroups of patients with early Parkinson’s disease (PD). Background: P2B001 is an investigational, fixed low-dose,…
  • 2023 International Congress

    Why is HAL effective in improving gait and balance function in Parkinson’s disease?

    N. Togashi, K. Tateno, Y. Kondo, M. Masanobu, A. Kawanami, K. Hasegawa (Sagamihara, Japan)

    Objective: We performed rehabilitation using a Hybrid Assisted Limb (HAL) for PD and found that gait and balance functions improved before and after HAL rehabilitation.…
  • 2023 International Congress

    Fecal tyrosine decarboxylase and motor response complications in Parkinson’s Disease

    JW. Hor, SY. Lim, TS. Toh, CW. Chong, CSJ. Teh, SL. Song, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the clinical correlates of gut microbe-derived tyrosine decarboxylase (tdc) and motor dysfunction in Parkinson’s Disease (PD) patients. Background: Gut microbe-derived tdc was…
  • 2023 International Congress

    The role of the glymphatic system on the severity and distribution of alpha-synuclein pathology in alpha-synuclein fibril induced rat model of Parkinson’s disease

    E. Gök Dursun, M. Karataş, M. çetinkaya, K. Karlı Oğuz, B. Tel, G. Yalçın çakmaklı, B. Elibol (Ankara, Turkey)

    Objective: The aim of this study is to investigate the contribution of the glymphatic system to the pathophysiology of Parkinson's disease (PD). Background: Neurotoxicity of…
  • 2023 International Congress

    Clozapine Therapy for Parkinson’s Disease Psychosis: A 21-Year Service Analysis

    W. Woods, T. Payne, N. Hoyle, O. Bandmann (Sheffield, United Kingdom)

    Objective: To review the demographic aspects, safety, and efficacy of Clozapine treatment for Parkinson’s Disease Psychosis (PDP) in a large patient cohort. Background: The impact…
  • 2023 International Congress

    The East London Parkinson Disease Project – preliminary results from a diverse population

    A. Zirra, KC. Dey, E. Camboe, T. Haque, A. Ben-Joseph, J. Kahan, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Lees, CR. Marshall, AJ. Noyce (London, United Kingdom)

    Objective: The East London Parkinson Disease (ELPD) project is a platform study to understand the manifestations and determinants of PD in a diverse population. Background:…
  • « Previous Page
  • 1
  • …
  • 236
  • 237
  • 238
  • 239
  • 240
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley